معرفی
Prof. A.K.L. (An) Reyners is a Professor in the Faculty of Medical Sciences at the University of Groningen, affiliated with the University Medical Center Groningen (UMCG). Their primary roles include Medical Oncologist and leadership in research groups such as Personalized Cancer Treatment (PCT) and Innovative Clinical Studies and Long-term Treatment Consequences in Cancer (InClinS). They are also a member of the committee for Evaluation of Oncology Resources (BOM).
Research Interests: Dr. Reyners' work focuses on gynecological malignancies, gastrointestinal stromal tumors, and palliative care. Their research spans clinical trials, genomic analysis, and improving patient outcomes through personalized therapy and long-term survivorship care. Key areas include molecular profiling of tumors, immune checkpoint inhibitors, and quality-of-life assessment after cancer treatment.
Recent Research Trends: Recent articles highlight advancements in cervical cancer immunotherapy (e.g., Cemiplimab trials), genomic studies of GIST mutations, and long-term effects of immune therapies. These reflect a focus on precision medicine and patient-centered oncology.
- Awards:
- Jaarprijs Palliatieve Zorg Impact (2019)
- ZonMW Parel (2019)
- ESMO Designated Centers of Integrated Oncology and Palliative Care (2009)
Advising & Grants: Supervised 12 PhD students and secured significant funding, including a €6.6M grant from the Dutch Cancer Society (KWF). Active in clinical trial leadership and collaborative studies across multiple institutions.
Labs/Teams: Leads research within PCT and InClinS groups, fostering interdisciplinary collaboration in oncology and palliative care.
